Fundraising Fox

CG Oncology

NASDAQ: CGON

Incorporated in Delaware · 9 known investors

CG Oncology develops an investigational oncolytic immunotherapy for urologic cancer patients, specifically targeting BCG-unresponsive non-muscle invasive bladder cancer. The company's approach combines engineered viral immunotherapy with potential combination therapies to improve patient quality of life.

BiotechHealthtechMedical Devices

Investors · 9

Decheng CapitalMenlo Park
Foresite CapitalWest Hollywood
Longitude CapitalMenlo Park · $10M – $30M
Palm Drive CapitalNew York · $500K – $5M
RA CapitalBoston
TCG CrossoverPalo Alto
ACORN BIOVENTURESreportedNew York
Ally Bridge GroupreportedNew York
ORI Capitalreported · 2 sourcesHong Kong

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

How Investors May Respond To CG Oncology (CGON) Revenue Growth Alongside a Widening Net Loss - Simply Wall St Newssimplywall.st · Aug 2026CG Oncology stock hits all-time high of 79.5 USD By Investing.cominvesting.com · Aug 2026RTW Investments reports 9.7% stake in CG Oncology | CGON SEC Filing - Form SCHEDULE 13G/Astocktitan.net · Aug 2026CG Oncology Stock: Circling Back After Huge Rally (NASDAQ:CGON) | Seeking Alphaseekingalpha.com · Aug 2026CG Oncology Highlights Q2 Results and Pipeline Progress - TipRanks.comtipranks.com · Aug 2026CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline - CG Oncology |cgoncology.com · Nov 2022

Frequently asked questions

What does CG Oncology do?
CG Oncology develops an investigational oncolytic immunotherapy for urologic cancer patients, specifically targeting BCG-unresponsive non-muscle invasive bladder cancer. The company's approach combines engineered viral immunotherapy with potential combination therapies to improve patient quality of life.
Who are CG Oncology's investors?
CG Oncology's investors include Decheng Capital, Foresite Capital, Longitude Capital, Palm Drive Capital, RA Capital, TCG Crossover, ACORN BIOVENTURES, Ally Bridge Group and 1 more.